Clinical Trial Update: Fixed Dose Comparison of Escitalopram to an Active Comparator in Severely Depressed Patients [Phase 4]

View source ↗

Summary

Phase 4 trial results comparing fixed doses of escitalopram to an active comparator in adults with severe major depressive disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Lexapro (escitalopram)

Snippet

Sponsor: Forest Laboratories | Conditions: Major Depressive Disorder | Phase 4 | Status: COMPLETED